Life-threatening paroxysmal supraventricular tachycardia developed during granulocyte transfusion therapy for neutropenia-related infection

Leukemia. 2000 Jul;14(7):1324-5. doi: 10.1038/sj.leu.2401826.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anticoagulants / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Citrates / adverse effects
  • Cytarabine / administration & dosage
  • Cytarabine / adverse effects
  • Cytarabine / analogs & derivatives
  • Granulocyte Colony-Stimulating Factor / adverse effects
  • Granulocytes / transplantation
  • Humans
  • Idarubicin / administration & dosage
  • Idarubicin / adverse effects
  • Infections / therapy*
  • Leukapheresis
  • Leukemia, Erythroblastic, Acute / complications*
  • Leukemia, Erythroblastic, Acute / drug therapy
  • Leukocyte Transfusion / adverse effects*
  • Male
  • Neutropenia / etiology
  • Neutropenia / therapy*
  • Sodium Citrate
  • Tachycardia, Supraventricular / etiology*

Substances

  • Anticoagulants
  • Citrates
  • Cytarabine
  • Granulocyte Colony-Stimulating Factor
  • Sodium Citrate
  • enocitabine
  • Idarubicin